Search results for: 'genetic technology'

Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of disorders. It can have long-term implications in preventive healthcare practices, including delayed onset of disease, treatment management, pharmacogenomics, and general wellness. One outcome of the COVID-19 pandemic has ...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...

03 Oct 2022  |  Global  |  Market Research

Global Prenatal Genetic Testing—Forecast to 2026

Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients

Infographics

×

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow. The study will help...

As healthcare evolves toward personalized solutions, everyday consumers are proactively taking responsibility for their health in ways unimaginable a decade ago. A direct-to-consumer genetic test (DTCGT) exemplifies this trend which can be purchased and used directly by consumers without the requirement of a prescription from a healthcare provider....

Predictive genetic testing refers to the testing of genetic mutations and variations in an individual to predict the risk of disease susceptibility and the inheritance of Mendelian diseases and other complex diseases. Genomic analysis studies such as genome-wide association studies (GWAS), SNP arrays, and the WGS of select populations have helped t...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

Rising healthcare and surgery costs are increasing the burden on healthcare systems, making it difficult for hospitals to offer high-quality care at affordable prices. Time-consuming manual processes that significantly impact surgeon time and workload, hospital cost increases due to delayed surgery, and low patient satisfaction levels due to human ...

In the rapidly evolving landscape of 2025, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

The objective of this study is to assess the market potential of current testing areas pertaining to the area of genetics such as diagnostic testing/screeening, relationship testing and predictive testing. Revenue forecast has been provided for 2010-2018 for each segment within the United Kingdom, Germany, France, Italy, Spain, Scandinavia and Bene...